Better Buy: Teladoc vs. Moderna
The pandemic has upended the healthcare industry, whether it's from the need to quickly but safely deliver new treatments to how patients can interact with their doctors to receive care.
Moderna (NASDAQ: MRNA) has been on the forefront of the creation of a COVID-19 vaccine, though doubts about whether there's more to the business after the pandemic subsides has begun to creep into the conversation. Similarly, Teladoc Health (NYSE: TDOC) benefited from the need for social distancing, but with the worst of the lockdowns a mere memory, worries about whether it can keep growing have held sway with many.
Below, two Motley Fool contributors argue that both of these healthcare stocks have a very bright future indeed. Which is the better buy?
Source Fool.com
